Impaired Expression of Membrane Type-2 and Type-3 Matrix Metalloproteinases in Endometriosis but Not in Adenomyosis

Impaired Expression of Membrane Type-2 and Type-3 Matrix Metalloproteinases in Endometriosis but Not in Adenomyosis

Matrix metalloproteinases (MMPs) play an important role in menstruation and endometriosis; however, the membrane-type matrix metalloproteinases (MT-MMPs) are not well studied in endometriosis and adenomyosis. We analyzed MT2-MMP (MMP15) and MT3-MMP (MMP16) in eutopic endometrium with and without end...

Full description

Bibliographic Details
Main Authors:	Jane B. Maoga, Muhammad A. Riaz, Agnes N. Mwaura, Georgios Scheiner-Bobis, Ezekiel Mecha, Charles O. A. Omwandho, Ivo Meinhold-Heerlein, Lutz Konrad
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Diagnostics
Subjects:	endometrium endometriosis adenomyosis membrane type-2 matrix metalloproteinase membrane type-3 matrix metalloproteinase
Online Access:	https://www.mdpi.com/2075-4418/12/4/779

Similar Items

Analysis of Membrane Type-1 Matrix Metalloproteinase (MT1-MMP, MMP14) in Eutopic and Ectopic Endometrium and in Serum and Endocervical Mucus of Endometriosis
by: Jane B. Maoga, et al.
Published: (2023-10-01)

Claudin-10 Expression Is Increased in Endometriosis and Adenomyosis and Mislocalized in Ectopic Endometriosis
by: Anna C. Loeffelmann, et al.
Published: (2022-11-01)

Eotaxin-induced expression of membrane type 1 matrix metalloproteinase mRNA in human eosinophils
by: Izumi Kurosaki, et al.
Published: (2000-01-01)

The Importance of Stromal Endometriosis in Thoracic Endometriosis
by: Ezekiel Mecha, et al.
Published: (2021-01-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target
by: Junya Ke, et al.
Published: (2021-11-01)

Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-α
by: Anna Janowska-Wieczorek, et al.
Published: (2012-07-01)

Extracellular matrix metalloproteinases in the etiopathogenesis of endometriosis: a systematic review and critical appraisal
by: M. Ζafrakas, et al.
Published: (2020-04-01)

Matrix metalloproteinases: expression and regulation in the endometrium during the estrous cycle and at the maternal-conceptus interface during pregnancy in pigs
by: Inkyu Yoo, et al.
Published: (2023-08-01)

Significance of matrix metalloproteinase-9 expression in the ectopic endometrial tissue of women with endometriosis
by: Ashraf M Kansouh, et al.
Published: (2019-01-01)

Development of Radiolabeled Membrane Type-1 Matrix Metalloproteinase Activatable Cell Penetrating Peptide Imaging Probes
by: Sander M. J. van Duijnhoven, et al.
Published: (2015-07-01)

Association of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels with diabetic foot ulcer in Egyptians with type 2 diabetes mellitus
by: Ghada H Sayed, et al.
Published: (2018-01-01)

Lunasin abrogates the expression of matrix metalloproteinases and reduction of type II collagen
by: Weihua Dai, et al.
Published: (2019-12-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

The role of matrix metalloproteinases in early and late gonarthrosis manifestations
by: Ekaterina V. Gladkova
Published: (2020-09-01)

ELISA study of matrix metalloproteinases 2, 7, 9 and their type 2 tissue inhibitor in the tumors of gastric cancer patients: clinical and pathologic correlations
by: E. S. Gershtein, et al.
Published: (2018-09-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Role of Betaglycan in TGF-β Signaling and Wound Healing in Human Endometriotic Epithelial Cells and in Endometriosis
by: Agnes N. Mwaura, et al.
Published: (2022-03-01)

The relationship between the first episode of wheezing and matrix metalloproteinases-9 and MMP-2 and tissue inhibitors of MMP-1 levels in preterm infants
by: Rabia Gonul Sezer, et al.
Published: (2013-01-01)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
by: Luis García-Onrubia, et al.
Published: (2020-08-01)

Role of type IV collagen and matrix metalloproteinase-9 in remodeling of the left ventricular in coronary artery disease
by: M. A. Popov, et al.
Published: (2019-09-01)

Metalloproteinase and tissue inhibitor of metalloproteinase in tuberculosis and malignant pleural effusion
by: Nesriene Mohamad El Margoushy, et al.
Published: (2013-04-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Menstruation Dysregulation and Endometriosis Development
by: Kevin K. W. Kuan, et al.
Published: (2021-10-01)

Matrix metalloproteinases in nephrotic syndrome; a vital but obscure field of research
by: Souparnika Sreelatha, et al.
Published: (2019-07-01)

The Effects of Botulinum Toxin A on Collagen Synthesis, Expression of MMP (matrix metalloproteinases)-1,2,9 and TIMP (tissue inhibitors of metalloproteinase)-1 in the Keloid Fibroblasts
by: Tai Suk Roh, et al.
Published: (2013-06-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Evaluation of two endometriosis models by transplantation of human endometrial tissue fragments and human endometrial mesenchymal cells
by: Mina Jafarabadi, et al.
Published: (2017-01-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Comparative analysis of content of the matrix metalloproteinase-9 in patients with acute cerebral strokes of different types
by: E. V. Baranova
Published: (2014-10-01)

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS IN TREATMENT OF RECURRENT PRE-MENSTRUAL ENDOMETRIAL HYPERPLASIA
by: Yu. E. Dobrokhotova, et al.
Published: (2016-09-01)

The activity of matrix metalloproteinases and the concentration of their tissue inhibitors in the blood serum of patients with type 2 diabetes mellitus, depending on the stage of compensation of the disease
by: A. V. Zubova, et al.
Published: (2021-12-01)

The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms
by: Miłosz Caban, et al.
Published: (2022-04-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

Endometrial Cancer Incidence in Endometriosis and Adenomyosis
by: Marjolein Hermens, et al.
Published: (2021-09-01)